David A Clarahan

Title: Innovations of David A. Clarahan in Injectable Gabapentin Compositions

Introduction

David A. Clarahan is an accomplished inventor based in Blaine, MN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of injectable compositions containing gabapentin. His innovative approach has led to advancements that enhance the safety and efficacy of these compositions.

Latest Patents

David A. Clarahan holds a patent for a process for producing injectable gabapentin compositions. This patent discusses injectable compositions containing gabapentin and the processes for preparing sterile injectable compositions. The process involves subjecting the compositions to heat, which surprisingly results in increased production of gabapentin lactam, a compound previously shown to be toxic. However, heated injectable compositions containing gabapentin have been found to be non-toxic when administered intrathecally. This finding provides a viable option for the production of sterile injectable compositions containing gabapentin.

Career Highlights

David A. Clarahan is associated with Medtronic, Inc., a leading company in the medical technology field. His work at Medtronic has allowed him to focus on innovative solutions that improve patient care and treatment options. With a patent portfolio that includes 1 patent, he has demonstrated his commitment to advancing medical science.

Collaborations

Throughout his career, David has collaborated with notable colleagues, including Keith Robert Hildebrand and Linda M. Page. These collaborations have contributed to the development of innovative solutions in the medical field.

Conclusion

David A. Clarahan's contributions to the field of injectable gabapentin compositions highlight his innovative spirit and dedication to improving medical treatments. His work continues to influence the pharmaceutical industry and enhance patient safety.